Latest Esg News

NEXTDC’s FY25 results reveal robust financial growth driven by surging AI and cloud demand, alongside a strategic joint venture to expand its Western Sydney data centre footprint.

NEXTDC Limited reported a 6% rise in FY25 revenue and underlying EBITDA, offset by a widened loss due to a $2.9 billion debt refinancing. The company’s strategic expansion in AI-ready data centres and a strengthened $6.4 billion debt facility position it for significant growth.

McMillan Shakespeare Limited reported a 14.1% rise in statutory net profit after tax to $95.3 million for FY25, alongside a fully franked final dividend of 77 cents per share. The company’s strategic investments in digital platforms and acquisitions underpin its growth trajectory.

humm Group Limited reported a remarkable 458% increase in net profit for FY25, driven by strong asset growth and effective cost management. The company also announced a final dividend and highlighted ongoing technology transformation and ESG commitments.

WAM Alternative Assets reported modest profit growth for FY2025, raised its fully franked final dividend by 15.4%, and outlined a strategic shift towards growth investments in its diversified alternative assets portfolio.

Advanced Braking Technology Ltd (ASX, ABV) reported a robust 25% revenue increase and 36% net profit growth for FY25, driven by international expansion and pioneering product launches in mining safety technology.

FINEOS Corporation Holdings plc reported a 4.2% increase in revenue to €67.1 million for H1 2025, alongside a significant 76% reduction in losses, driven by subscription growth and operational efficiencies.

Resimac Group Ltd delivered a robust FY25 performance, marked by strong organic growth in home loans and asset finance, bolstered by the strategic acquisition of Westpac's $1.5 billion auto portfolio. The company raised dividends to 19 cents fully franked, reflecting confidence amid rising impairment expenses.

Clinuvel Pharmaceuticals reports steady financial growth with an 8% rise in revenue and 2% profit increase, while expanding its US commercial footprint and completing recruitment for a pivotal vitiligo trial.

MoneyMe Limited reported a robust FY25 with a $1.6 billion loan book, 28% growth from FY24, and a $24 million operating cash profit, signaling a strong turnaround. The fintech lender also improved credit quality and expanded funding capacity, setting the stage for future growth.

MONEYME Limited reported a robust FY25 with a 28% increase in its loan book to $1.6 billion and a positive operating cash profit of $24 million, underpinned by improved credit quality and strategic funding initiatives.

MoneyMe Limited posted a statutory net loss of $66.6 million for FY25, driven by accounting adjustments and credit loss provisions despite strong loan book growth and funding advances. The company is poised for growth with a new credit card launch and ongoing AI integration.